This site is intended for Healthcare Professionals Only
We deliver and support renal therapies across the continuum of care, including the innovative HDx.
Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve end-stage kidney disease patient clinical outcomes and increase lifestyle flexibility.
Haemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.
Innovative Expanded Haemodialysis (HDx) therapy is the next evolution in haemodialysis treatment.
Learn more about Baxter’s key products for Renal Care – across the continuum of care.
Peritoneal Dialysis
Haemodialysis
Research enabling innovative renal care and inspirational patient stories
Explore the research enabling innovative Renal Care.
Patients’ journeys inspire our work and drive our commitment.
Access resources for Baxter’s broader Renal Care portfolio.
This site is intended for Healthcare Professionals Only
You are now leaving this site and will continue on an external site.